Bluejay Diagnostics, Inc. (BJDX) Financials
BJDX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 11.5 million | 2.1 million |
| March 31, 2026 | 5.6 million | 1.4 million |
| Dec. 31, 2025 | 7.1 million | 1.1 million |
| Sept. 30, 2025 | 4.9 million | 1.2 million |
BJDX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -1.6 million | ? |
| March 31, 2026 | -1.6 million | ? |
| Dec. 31, 2025 | -1.6 million | 74 |
| Sept. 30, 2025 | -1.4 million | 183 |
BJDX Net Income
No data available :(
BJDX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 9.6 million | - | 2419 |
| March 31, 2026 | 3.7 million | - | 100521 |
| Dec. 31, 2025 | 5.2 million | - | 120211 |
| Sept. 30, 2025 | 3.1 million | - | 142990 |
BJDX Shares Outstanding
BJDX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 142773 | 1.4 million | 911318 | - |
| March 31, 2026 | 18990 | 808957 | 1.1 million | - |
| Dec. 31, 2025 | 173743 | 586144 | 875603 | - |
| Sept. 30, 2025 | 3 | 785608 | 831339 | - |
BJDX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | 49558 |
| Dec. 31, 2025 | - | 48809 |
| Sept. 30, 2025 | - | 31624 |
BJDX
Price: $0.90
52 week price:
Earnings Per Share: -2.24 USD
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 114300
Market Capitalization: 861296